A Phase 1, Open Label, Randomized, 2-Period, 2-Treatment, Crossover Study to Assess the Effect of Plazomicin on the Pharmacokinetics of Metformin in Healthy Subjects

Trial Profile

A Phase 1, Open Label, Randomized, 2-Period, 2-Treatment, Crossover Study to Assess the Effect of Plazomicin on the Pharmacokinetics of Metformin in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Oct 2017

At a glance

  • Drugs Plazomicin (Primary) ; Metformin
  • Indications Bacteraemia; Gram-negative infections; Nosocomial pneumonia; Pyelonephritis; Respiratory tract infections; Urinary tract infections; Yersinia infections
  • Focus Pharmacokinetics
  • Sponsors Achaogen
  • Most Recent Events

    • 09 Oct 2017 Status changed from active, no longer recruiting to completed.
    • 01 Oct 2017 Planned End Date changed from 30 Sep 2017 to 13 Oct 2017.
    • 01 Oct 2017 Planned primary completion date changed from 24 Sep 2017 to 13 Oct 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top